1,836
Views
11
CrossRef citations to date
0
Altmetric
Short Communication

LC-QTOF-MS analysis of xanthone content in different parts of Garcinia mangostana and its influence on cholinesterase inhibition

, &
Pages 1433-1441 | Received 13 Feb 2020, Accepted 15 Jun 2020, Published online: 01 Jul 2020

References

  • NBJ’s Supplement Business Report. 2015. Available from: https://www.newhope.com/nbj [last accessed 8 Aug 2019].
  • Walker EB. HPLC analysis of selected xanthones in mangosteen fruit. J Sep Sci 2007;30:1229–34.
  • Pothitirat W, Gritsanapan W. Thin-layer chromatography-densitometric analysis of alpha-mangostin content in Garcinia mangostana fruit rind extracts. J AOAC Int 2008;91:1145–8.
  • Wittenauer J, Falk S, Schweiggert-Weisz U, Carle R. Characterisation and quantification of xanthones from the aril and pericarp of mangosteens (Garcinia mangostana L.) and a mangosteen containing functional beverage by HPLC–DAD–MSn. Food Chem 2012;134:445–52.
  • Ji X, Avula B, Khan IA. Quantitative and qualitative determination of six xanthones in Garcinia mangostana L. by LC-PDA and LC-ESI-MS. J Pharm Biomed Anal 2007;43:1270–6.
  • Lahiri DK, Farlow MR, Greig NH, Sambamurti K. Current drug targets for Alzheimer’s disease treatment. Drug Dev Res 2002;56:267–81.
  • Sramek JJ, Zarotsky V, Cutler NR. Review of drug development and therapeutic role of cholinesterase inhibitors in Alzheimer’s disease. Drug Dev Res 2002;56:347–53.
  • Tougu V. Acetylcholinesterase: Mechanism of catalysis and inhibition. Cent Nerv Syst Agents Med Chem 2001;1:155–70.
  • Ballard CG, O'Brien JT, Reichelt K, Perry EK. Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa. J Clin Psychiatry 2002;63:553–8.
  • Howes MJ, Perry NS, Houghton PJ. Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders. Phytother Res 2003;17:1–18.
  • Sonsalla PK, Wong LY, Harris SL, et al. Delayed caffeine treatment prevents nigral dopamine neuron loss in a progressive rat model of Parkinson’s disease. Exp Neurol 2012;234:482–7.
  • Laurent C, Eddarkaoui S, Derisbourg M, Leboucher A, et al. Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology. Neurobiol Aging 2014;35:2079–90.
  • Murray AP, Faraoni MB, Castro MJ, et al. Natural AChE inhibitors from plants and their contribution to Alzheimer’s disease therapy. Curr Neuropharmacol 2013;11:388–413.
  • Khaw KY, Choi SB, Tan SC, et al. Prenylated xanthones from mangosteen as promising cholinesterase inhibitors and their molecular docking studies. Phytomedicine 2014;21:1303–9.
  • Khaw KY, Murugaiyah V, Khairuddean M, Tan WN. Garcinexanthone G, a selective butyrylcholinesterase inhibitor from the stem bark of Garcinia atroviridis. Nat Prod Sci 2018;24:88–92.
  • Li P, Yang Z, Tang B, et al. Identification of xanthones from the mangosteen pericarp that inhibit the growth of Ralstonia solanacearum. ACS Omega 2020; 2020/01/145:334–43.
  • Kumar V, Chandra S. LC-ESI/MS determination of xanthone and secoiridoid glycosides from in vitro regenerated and in vivo Swertia chirayita. Physiol Mol Biol Plants 2015;21:51–60.
  • Mamat SF, Azizan KA, Baharum SN, et al. GC-MS and LC-MS analyses reveal the distribution of primary and secondary metabolites in mangosteen (Garcinia mangostana Linn.) fruit during ripening. Scientia Horticulturae 2020;262:109004.
  • Gondokesumo ME, Pardjianto B, Sumitro SB, et al. Xanthones analysis and antioxidant activities analysis (applying ESR) of six different maturity levels of mangosteen rind extract (Garcinia mangostana Linn.). Pharmacogn J 2019;11:369–73.
  • Fan LY, Chiu MJ. Combotherapy and current concepts as well as future strategies for the treatment of Alzheimer’s disease. Neuropsychiatr Dis Treat 2014;10:439–51.
  • Arnold SE, Kumar A. Reversible dementias. Med Clin North Am 1993;77:215–30.
  • Greig NH, Utsuki T, Ingram DK, et al. Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent . Proc Natl Acad Sci USA 2005;102:17213–8.
  • Wang Z, Ma Z, Wang L, et al. Active anti-acetylcholinesterase component of secondary metabolites produced by the endophytic fungi of Huperzia serrata. Electr J Biotechnol 2015;18:399–405.
  • Ding X, Ouyang MA, Liu X, Wang RZ. Acetylcholinesterase inhibitory activities of flavonoids from the leaves of Ginkgo biloba against brown planthopper. J Chem 2013; 2013:1–4.
  • Mathew M, Subramanian S. In vitro screening for anti-cholinesterase and antioxidant activity of methanolic extracts of Ayurvedic medicinal plants used for cognitive disorders. PLOS One 2014;9:e86804.